Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.

Flavan-3-ols, occurring in monomeric, as well as in oligomeric and polymeric forms (also known as condensed tannins or proanthocyanidins), are among the most abundant and bioactive dietary polyphenols, but their in vivo health effects in humans may be limited because of their recognition as xenobiot...

Descripción completa

Detalles Bibliográficos
Autores: Monagas, Maria, Urpí Sardà, Mireia, Sánchez-Patán, Fernando, Garrido, Ignacio, Llorach, Rafael, Gómez-Cordovés, Carmen, Andrés Lacueva, Ma. Cristina, Bartolomé, Begoña
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2010
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/68567
Acceso en línea:https://hdl.handle.net/2445/68567
Access Level:acceso abierto
Palabra clave:Biotransformació (Metabolisme)
Flavonoides
Genomes
Xenobiòtics
Absorció intestinal
Biotransformation (Metabolism)
Flavonoids
Xenobiotics
Intestinal absorption
id ES_cff560fcc8cd4cc7b3ede358ca046ff3
oai_identifier_str oai:recercat.cat:2445/68567
network_acronym_str ES
network_name_str España
repository_id_str
spelling Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.Monagas, MariaUrpí Sardà, MireiaSánchez-Patán, FernandoGarrido, IgnacioLlorach, RafaelGómez-Cordovés, CarmenAndrés Lacueva, Ma. CristinaBartolomé, BegoñaBiotransformació (Metabolisme)FlavonoidesGenomesXenobiòticsAbsorció intestinalBiotransformation (Metabolism)FlavonoidsGenomesXenobioticsIntestinal absorptionFlavan-3-ols, occurring in monomeric, as well as in oligomeric and polymeric forms (also known as condensed tannins or proanthocyanidins), are among the most abundant and bioactive dietary polyphenols, but their in vivo health effects in humans may be limited because of their recognition as xenobiotics. Bioavailability of flavan-3-ols is largely influenced by their degree of polymerization; while monomers are readily absorbed in the small intestine, oligomers and polymers need to be biotransformed by the colonic microbiota before absorption. Therefore, phenolic metabolites, rather than the original high molecular weight compounds found in foods, may be responsible for the health effects derived from flavan-3-ol consumption. Flavan-3-ol phenolic metabolites differ in structure, amount and excretion site. Phase II or tissular metabolites derived from the small intestine and hepatic metabolism are presented as conjugated derivatives (glucuronic acid or sulfate esters, methyl ether, or their combined forms) of monomeric flavan-3-ols and are preferentially eliminated in the bile, whereas microbial metabolites are rather simple conjugated lactones and phenolic acids that are largely excreted in urine. Although the colon is seen as an important organ for the metabolism of flavan-3-ols, the microbial catabolic pathways of these compounds are still under consideration, partly due to the lack of identification of bacteria with such capacity. Studies performed with synthesized or isolated phase II conjugated metabolites have revealed that they could have an effect beyond their antioxidant properties, by interacting with signalling pathways implicated in important processes involved in the development of diseases, among other bioactivities. However, the biological properties of microbe-derived metabolites in their actual conjugated forms remain largely unknown. Currently, there is an increasing interest in their effects on intestinal infections, inflammatory intestinal diseases and overall gut health. The present review will give an insight into the metabolism and microbial biotransformation of flavan-3-ols, including tentative catabolic pathways and aspects related to the identification of bacteria with the ability to catabolize these kinds of polyphenols. Also, the in vitro bioactivities of phase II and microbial phenolic metabolites will be covered in detail.Royal Society of Chemistry2015201520102015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion21 p.application/pdfhttps://hdl.handle.net/2445/68567Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: http://dx.doi.org/10.1039/c0fo00132eFood & Function, 2010, vol. 1, num. 3, p. 233-253http://dx.doi.org/10.1039/c0fo00132e(c) Royal Society of Chemistry, 2010info:eu-repo/semantics/openAccessoai:recercat.cat:2445/685672026-05-29T05:05:01Z
dc.title.none.fl_str_mv Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
title Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
spellingShingle Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
Monagas, Maria
Biotransformació (Metabolisme)
Flavonoides
Genomes
Xenobiòtics
Absorció intestinal
Biotransformation (Metabolism)
Flavonoids
Genomes
Xenobiotics
Intestinal absorption
title_short Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
title_full Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
title_fullStr Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
title_full_unstemmed Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
title_sort Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
dc.creator.none.fl_str_mv Monagas, Maria
Urpí Sardà, Mireia
Sánchez-Patán, Fernando
Garrido, Ignacio
Llorach, Rafael
Gómez-Cordovés, Carmen
Andrés Lacueva, Ma. Cristina
Bartolomé, Begoña
author Monagas, Maria
author_facet Monagas, Maria
Urpí Sardà, Mireia
Sánchez-Patán, Fernando
Garrido, Ignacio
Llorach, Rafael
Gómez-Cordovés, Carmen
Andrés Lacueva, Ma. Cristina
Bartolomé, Begoña
author_role author
author2 Urpí Sardà, Mireia
Sánchez-Patán, Fernando
Garrido, Ignacio
Llorach, Rafael
Gómez-Cordovés, Carmen
Andrés Lacueva, Ma. Cristina
Bartolomé, Begoña
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Biotransformació (Metabolisme)
Flavonoides
Genomes
Xenobiòtics
Absorció intestinal
Biotransformation (Metabolism)
Flavonoids
Genomes
Xenobiotics
Intestinal absorption
topic Biotransformació (Metabolisme)
Flavonoides
Genomes
Xenobiòtics
Absorció intestinal
Biotransformation (Metabolism)
Flavonoids
Genomes
Xenobiotics
Intestinal absorption
description Flavan-3-ols, occurring in monomeric, as well as in oligomeric and polymeric forms (also known as condensed tannins or proanthocyanidins), are among the most abundant and bioactive dietary polyphenols, but their in vivo health effects in humans may be limited because of their recognition as xenobiotics. Bioavailability of flavan-3-ols is largely influenced by their degree of polymerization; while monomers are readily absorbed in the small intestine, oligomers and polymers need to be biotransformed by the colonic microbiota before absorption. Therefore, phenolic metabolites, rather than the original high molecular weight compounds found in foods, may be responsible for the health effects derived from flavan-3-ol consumption. Flavan-3-ol phenolic metabolites differ in structure, amount and excretion site. Phase II or tissular metabolites derived from the small intestine and hepatic metabolism are presented as conjugated derivatives (glucuronic acid or sulfate esters, methyl ether, or their combined forms) of monomeric flavan-3-ols and are preferentially eliminated in the bile, whereas microbial metabolites are rather simple conjugated lactones and phenolic acids that are largely excreted in urine. Although the colon is seen as an important organ for the metabolism of flavan-3-ols, the microbial catabolic pathways of these compounds are still under consideration, partly due to the lack of identification of bacteria with such capacity. Studies performed with synthesized or isolated phase II conjugated metabolites have revealed that they could have an effect beyond their antioxidant properties, by interacting with signalling pathways implicated in important processes involved in the development of diseases, among other bioactivities. However, the biological properties of microbe-derived metabolites in their actual conjugated forms remain largely unknown. Currently, there is an increasing interest in their effects on intestinal infections, inflammatory intestinal diseases and overall gut health. The present review will give an insight into the metabolism and microbial biotransformation of flavan-3-ols, including tentative catabolic pathways and aspects related to the identification of bacteria with the ability to catabolize these kinds of polyphenols. Also, the in vitro bioactivities of phase II and microbial phenolic metabolites will be covered in detail.
publishDate 2010
dc.date.none.fl_str_mv 2010
2015
2015
2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/68567
url https://hdl.handle.net/2445/68567
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: http://dx.doi.org/10.1039/c0fo00132e
Food & Function, 2010, vol. 1, num. 3, p. 233-253
http://dx.doi.org/10.1039/c0fo00132e
dc.rights.none.fl_str_mv (c) Royal Society of Chemistry, 2010
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Royal Society of Chemistry, 2010
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 21 p.
application/pdf
dc.publisher.none.fl_str_mv Royal Society of Chemistry
publisher.none.fl_str_mv Royal Society of Chemistry
dc.source.none.fl_str_mv Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420130178433024
score 15.812455